Attenuation of postoperative cognitive dysfunction by amantadine
Attenuation of postoperative cognitive dysfunction by amantadine
批准号:
9125718
负责人:
ZHIYI ZUO
金额:
$23.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2017-04-30
关键词:
AffectAgeAmantadineAmericanAnesthesia proceduresAnestheticsAnimalsAntiviral AgentsAreaAttentionAttenuatedBiochemicalBrainBrain regionCardiac Surgery proceduresCell Culture TechniquesClinicalEffectivenessElderlyFunctional disorderFutureGeneral AnesthesiaGrowthHarvestHippocampus (Brain)HumanImpaired cognitionIntentionInterventionIsofluraneLearningLengthMediatingMemoryMemory impairmentMethodsNeurodegenerative DisordersNeurogliaOperative Surgical ProceduresParkinson DiseasePatientsPharmaceutical PreparationsPopulationProcessProductionQuality of lifeRattusRisk FactorsRoleTestingTranslationsTraumatic Brain InjuryViralagedattenuationbaseconditioned feardesignimprovedimproved outcomein vivomalemortalityneuroinflammationneurotrophic factorolder patientpost-operative cognitive dysfunctionpre-clinicalpublic health relevanceresearch studytherapy designyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): More than 20 million people each year undergo surgery in the U.S.A. Post-operative cognitive dysfunction (POCD), a documented clinical entity that occurs more frequently in elderly patients, has drawn significant attention from the public and professionals. Because the issue is obviously significant, there is an urgent need to identify interventions to attenuate POCD. Our preliminary study showed that amantadine, a clinically used anti-viral agent that is also used in treating various neurodegenerative diseases, reduced surgery (right carotid exploration)-induced learning and memory impairment as well as neuroinflammation in young adult rats. Amantadine also increased glial cell-derived growth factor (GDNF) in the brain. GDNF has been shown to reduce microglial activation in a previous study. In addition, our preliminary study showed that amantadine attenuated surgery-induced learning and memory impairment in elderly rats. We hypothesize that GDNF mediates the amantadine effects on surgery-induced neuroinflammation as well as learning and memory impairment in aged rats. In this project, we will determine whether: 1) the duration of amantadine application affects the effectiveness of amantadine to attenuate surgery-induced learning and memory impairment in aged rats; 2) amantadine reduces surgery-induced neuroinflammation through GDNF; and 3) inhibition of GDNF blocks amantadine-induced attenuation of cognitive impairment after carotid arterial exploration. We will use old adult male rats and subject them to right carotid arterial exploration. Animals will be anesthetized by the volatile anesthetic isoflurane. Learning and memory will be evaluated by Barnes maze and fear conditioning. Various brain regions will be harvested for biochemical examination. These studies may provide preclinical evidence for using amantadine to attenuate POCD. Our studies may also reveal target molecules for the amantadine effects, which may help design interventions for POCD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
-
批准号:9884819
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2018
-
负责人:ZHIYI ZUO
-
依托单位:
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
-
批准号:10380594
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2018
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:9769801
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:10246802
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:10012940
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8293755
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8727057
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8549264
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7879848
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2009
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:6826226
-
项目类别:
-
资助金额:$28.21万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:6728964
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:7163021
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:7004486
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6696926
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7173747
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:8067162
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7522567
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6574563
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7014017
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6844305
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: